America's Biggest Women's Road Cycling Event Selected as First U.S. Event on First-Ever UCI Women's WorldTour
LOS ANGELES, CA (September 24, 2015) - The 2016 Amgen Tour of California, America's biggest and most prestigious cycling event, is once again increasing its commitment to Women's cycling by staging a four day/four stage Women's race May 19-22 as part of the 2016 event it was announced today by Kristin Klein, Executive Director, Amgen Tour of California and senior vice president, AEG Sports, owners and operators of the Amgen Tour of California. It was also confirmed by cycling's international governing body, Union Cycliste Internationale (UCI) that the race will be part of the first-ever UCI Women's WorldTour (WWT).
Announced earlier today at the UCI Road World Championships, the WWT will be a combination of one-day and multi-day stage races and will run for 30 days from March to October across Europe, China and the United States including the recently formed one-day races La Course by Le Tour de France and La Madrid Challenge by La Vuelta. Multi-day events will include the Aviva Women's Tour of Great-Britain and the historical Giro d'Italia Internazionale Femminile. The Amgen Tour of California Women's Race empowered withSRAM will be the first WWT event held on U.S. soil and one of only two U.S. races included in the WWT's inaugural year (the Philadelphia International Cycling Classic being the other).
In 2015, the Amgen Tour of California Women's Race empowered with SRAM became the first-ever event to feature four days of Women's racing (three-day stage race and a Women's Time Trial) as part of the program.
"With four days of women's racing scheduled for 2016, I am proud that once again the Amgen Tour of California is taking an industry-leading role in creating a platform that promotes women's cycling on the biggest national stage," said Klein. "It is also gratifying that because of the great admiration and positive reputation the Amgen Tour of California Women's Race empowered with SRAM contines to build among the global clycling community, our upcoming event has been chosen to be the first women's race on U.S. soil to be held as part of the new UCI Women's WorldTour."
The top 20 UCI Women's Teams will be invited to participate in each event with some organizers choosing to increase the size of the peloton by offering a greater number of teams the chance to race. There will be WWT leader and young (U23) leader jerseys and individual races will also be allowed to introduce their own jerseys. As well as competing for victories in the individual races, the riders will also battle to position themselves in the overall WWT rankings.
Amgen Tour of California organizers will be announcing 2016 Host Cities in the coming weeks.
About the Amgen Tour of California
The Amgen Tour of California is a Tour de France-style cycling road race created and presented by AEG that challenges the world's top professional cycling teams to compete along a demanding course that traverses hundreds of miles of California's iconic highways, byways and coastlines each spring. The teams chosen to participate have included Olympic medalists, Tour de France contenders and World Champions. Amgen Tour of California is listed on the international professional cycling calendar (2 HC, meaning "beyond category"), awarding important, world-ranking points to the top finishers. More information is available at www.amgentourofcalifornia.com.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Founder and operators of the Amgen Tour of California, AEG is one of the leading sports and entertainment presenters in the world. AEG, a wholly owned subsidiary of The Anschutz Company, owns or controls a collection of companies including facilities such as STAPLES Center, StubHub Center, Sprint Center, The O2, Mercedes-Benz Arena, Microsoft Theater, L.A. LIVE and Best Buy Theater Times Square; sports franchises including the LA Kings (NHL), two Major League Soccer franchises, two hockey franchises operated in Europe, management of privately held shares of the Los Angeles Lakers; AEG Live, the organization's live-entertainment division, is a collection of companies dedicated to all aspects of live contemporary music performance, touring and a variety of programming and multi-media production. For more information, visit AEG today at www.aegworldwide.com.
Michael Roth AEG
Amgen Tour of California